Your browser doesn't support javascript.
loading
Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature.
Cheok, Kathleen P L; Farrow, Adrian; Springell, Deborah; O'Reilly, Maeve; Morley, Simon; Stone, Neil; Roddie, Claire.
Afiliação
  • Cheok KPL; University College London Hospital NHS Foundation Trust, London, UK; University College London Cancer Institute, London, UK. Electronic address: kathleen.cheok@nhs.net.
  • Farrow A; University College London Hospital NHS Foundation Trust, London, UK.
  • Springell D; University College London Hospital NHS Foundation Trust, London, UK.
  • O'Reilly M; University College London Hospital NHS Foundation Trust, London, UK.
  • Morley S; University College London Hospital NHS Foundation Trust, London, UK.
  • Stone N; University College London Hospital NHS Foundation Trust, London, UK.
  • Roddie C; University College London Hospital NHS Foundation Trust, London, UK; University College London Cancer Institute, London, UK.
Lancet Infect Dis ; 24(4): e256-e265, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38310904
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mucormicose Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Humans / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mucormicose Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Humans / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article